Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Rob Miller is reader in clinical infection at University College London and honorary professor at the London School of Hygiene and Tropical Medicine. After qualifying from St George's Hospital Medical School in 1980, he trained in general (internal) medicine, Respiratory Medicine and Intensive Care. His research interests are the basic biology of human Pneumocystis infection and clinical aspects of infection in the immunosuppressed host. He is co-editor of Sexually Transmitted Infections, part of the BMJ Publishing Group.
Read articles by Rob Miller
| Competing Interests |
|---|
| Have you in the past five years accepted the following from an organisation that may in any way gain or lose financially from the publication of papers in the BMJ? |
| a) Reimbursement for attending a symposium? |
| No |
| b) A fee for speaking? |
|
In 2006 I received £650 from Gilead and £300 from Glaxo Smith Kline as speaker's fees; I have not received any payment from pharmaceutical companies in the previous 2 years. |
| c) A fee for organising education? |
| No |
| d) Funds for research? |
| No |
| e) Funds for a member of staff? |
| No |
| f) Fees for consulting? |
|
No |
| Have you in the past five years been employed by any organisation that may in any way gain or lose financially from the publication of papers in the BMJ? |
| a) Do you hold any stocks or shares in an organisation? |
| No |
| b) Do you have any other competing financial interests? |
| I receive an honorarium from editing Sexually Transmitted Infections, part of the BMJ Publishing Group |
|
|